References
#1 in Business Subscribe Email Print

You are here: Home > Automotive > Automotive > And Ford Lives On

Tags

  • cycle
  • combinations
  • which
  • developing combination
  • company needs
  • developing combination

  • Links

  • Finding Intuition - The Seven Steps to Unlock this Gift
  • Stress Healing with Energy... Pranic, Tantric, and Reiki
  • World's Second Biggest Advertiser Prepares for Their Internet Future
  • References - And Ford Lives On

    Big options are now coming down the way for Ford. These options may either create an air of new life to the automaker or be li
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    able for its second death in the automotive world.

    After its dwindling sales in the past few quarters, Ford is having a hard
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ime to cope up with the losses. Losses seem to be mounting and the instant solution of the automaker is to design a work plan
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    to pull it upwards. This plan is called the ‘Way Forward’. Said plan called for the closure of 14 plants and 30,000 job cuts b
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    year 2012.

    However, experts are saying that there are other issues that the automaker must respond to. These issues include
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    he determination of whether its ailing brands like Lincoln Mercury and Jaguar should sell or close. Another concern is the exo
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    dus of Ford’s top executives. Lastly, Ford must also concentrate on its bread-and-butter vehicles like the F-Series pickup tru
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    k. Ford parts used in said vehicles are now being matched by Chevy in its Silverado version of pickup truck.

    Rebecca Lindland
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    an automotive analyst at consultancy Global Insight said, “Ford is good at cutting costs, but it’s not very good at selling p
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    roduct, and that’s what brings in the money. The company needs to get people into their showrooms. The baby boomers are the on
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    s who rode Nissan, Toyota and Honda to where they are today, and there are lots of them who have never darkened the door of a
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    omestic automaker’s showroom. That is why we don’t anticipate many big changes for the domestic automakers like Ford for decad
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    es. Baby boomers are in their peak buying years.”

    “One of the things we are so concerned about at Ford is the design directio
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    . Where is it going, and who is leading the charge? What is a Ford car? The company needs to get some kind of theme, or person
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    lity. Chrysler was able to do it with the 300 and Ford had it with the Mustang and the F-Series, but they have stumbled badly
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    since then, and people don’t know what a Ford car stands for,” Lindland further added.

    On one hand, Daniel Gorrell, vice pres
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    dent at research and consulting firm Strategic Vision in San Diego advised that Ford should take drastic changes to help allev
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ate its standing in the automotive industry. Gorrell said, “[Ford is] caught up the general malaise of domestic automobile ind
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ustry. It’s under siege [from Asian automakers], and it hasn’t really demonstrated an ability to get over its problems. The bu
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    iness environment is very difficult for them now, and their mix of products no longer reflects what consumers are looking for.


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.references.org.ua/article/385027/references-And-Ford-Lives-On.html">And Ford Lives On</a>

    BB link (for phorums):
    [url=http://www.references.org.ua/article/385027/references-And-Ford-Lives-On.html]And Ford Lives On[/url]

    Related Articles:

    Article Marketing-Resource Box Revealed

    Are You Using Money To Measure Your Success?

    Fighting Declawing...Tooth and Nail

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com